These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36618206)

  • 41. Clinical Utilization Pattern of Multiple Strengths of Glimepiride and Metformin Fixed Dose Combinations in Indian Type 2 Diabetes Patients.
    Ag U; K P; J G; S V; Mv A
    J Assoc Physicians India; 2020 Jul; 68(7):57-61. PubMed ID: 32602682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. China type 2 diabetes treatment status survey of treatment pattern of oral drugs users.
    Ji L; Lu J; Weng J; Jia W; Tian H; Zhu D; Xing X; Guo L
    J Diabetes; 2015 Mar; 7(2):166-73. PubMed ID: 24809622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.
    Lin KD; Chang YH; Wang CL; Yang YH; Hsiao PJ; Li TH; Shin SJ
    Transl Res; 2008 Jun; 151(6):309-14. PubMed ID: 18514142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.
    Lin SN; Phang KK; Toh SH; Chee KH; Zaman Huri H
    Front Endocrinol (Lausanne); 2020; 11():448. PubMed ID: 32754118
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of Prescription Pattern of Anti-diabetic Medications in a Teaching Hospital in North India.
    Jha H; Khan TA; Khan N; Fatima G
    Cureus; 2024 Jun; 16(6):e63343. PubMed ID: 39070354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
    Heintjes EM; Overbeek JA; Hall GC; Prieto-Alhambra D; Lapi F; Hammar N; Bezemer ID
    Clin Ther; 2017 Nov; 39(11):2296-2310.e14. PubMed ID: 29108837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.
    Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Chen WM; Yeh YH; Kuo CT; See LC; Lip GYH
    Cardiovasc Diabetol; 2022 Jun; 21(1):118. PubMed ID: 35765074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia.
    Wabe NT; Angamo MT; Hussein S
    N Am J Med Sci; 2011 Sep; 3(9):418-23. PubMed ID: 22362451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug use evaluation of diabetes mellitus in hospitalized patients of a tertiary care referral hospital.
    Khalam A; Dilip C; Shinu C
    J Basic Clin Physiol Pharmacol; 2012; 23(4):173-7. PubMed ID: 23072848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to Clinical Guidelines on STATIN Prescribing Among Diabetic Patients Aged 40-75 Years Old in a Primary Care Setting: A Cross-Sectional Study.
    Abukhalil AD; Alyan M; AbuAita W; Al-Shami N; Naseef HA
    Patient Prefer Adherence; 2022; 16():1855-1863. PubMed ID: 35942227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019.
    Lee KA; Jin HY; Kim YJ; Im YJ; Kim EY; Park TS
    J Korean Med Sci; 2021 Sep; 36(36):e230. PubMed ID: 34519186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
    Le P; Ayers G; Misra-Hebert AD; Herzig SJ; Herman WH; Shaker VA; Rothberg MB
    Diabetes Care; 2022 May; 45(5):1107-1115. PubMed ID: 35076695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pattern of anti-diabetic drugs prescribed in a tertiary care hospital of Bangladesh.
    Ahmed Z; Hafez MA; Bari MA; Akhter J
    Int J Basic Clin Pharmacol; 2016; 5(1):6-12. PubMed ID: 26855961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.
    Ling AW; Chan CC; Chen SW; Kao YW; Huang CY; Chan YH; Chu PH
    Cardiovasc Diabetol; 2020 Nov; 19(1):188. PubMed ID: 33158436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study).
    Das AK; Saboo B; Unnikrishnan AG
    Diabetes Metab Syndr Obes; 2021; 14():2693-2700. PubMed ID: 34163197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes.
    Katsiki N; Kazakos K; Triposkiadis F
    Expert Opin Pharmacother; 2022 Dec; 23(17):1957-1974. PubMed ID: 36322877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.